Awny Farajallah

Author PubWeight™ 21.24^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.	N Engl J Med	2009	4.54
2	Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.	Ann Intern Med	2011	4.21
3	Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.	J Infect Dis	2011	2.12
4	Escherichia coli: development of carbapenem resistance during therapy.	Clin Infect Dis	2005	1.89
5	Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients.	J Acquir Immune Defic Syndr	2009	1.62
6	Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF.	AIDS Patient Care STDS	2010	1.14
7	A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results.	HIV Clin Trials	2012	1.13
8	Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study.	AIDS Patient Care STDS	2012	1.00
9	Changes in bone mineral density after 96 weeks of treatment with atazanavir/ritonavir or lopinavir/ritonavir plus tenofovir DF/emtricitabine in treatment-naive patients with HIV-1 infection: the CASTLE body composition substudy.	J Acquir Immune Defic Syndr	2015	0.84
10	Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir.	J Antimicrob Chemother	2011	0.83
11	Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study.	J Antimicrob Chemother	2011	0.81
12	Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection.	Clin Drug Investig	2014	0.78
13	Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine.	AIDS Care	2011	0.76